Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer.
暂无分享,去创建一个
Peter Gibbs | L. Turnbull | P. Gibbs | M. Pickles | M. Lowry | Lindsay W Turnbull | Martin D Pickles | Martin Lowry
[1] J. B. Moody,et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.
[2] R. Gillies,et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. , 2004, Neoplasia.
[3] Michal Neeman,et al. Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. , 2004, Neoplasia.
[4] Stephan E Maier,et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.
[5] T. Chenevert,et al. Modeled Temporal Responses of Tumor Volume and ADC to Anticancer Therapy , 2004 .
[6] Alexander de Vries,et al. Preliminary Results on the Influence of Chemoradiation on Apparent Diffusion Coefficients of Primary Rectal Carcinoma Measured by Magnetic Resonance Imaging , 2003, Strahlentherapie und Onkologie.
[7] Jürgen Griebel,et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.
[8] Bradford A Moffat,et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.
[9] Jürgen Griebel,et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. , 2003, European journal of radiology.
[10] A R Padhani,et al. Functional MRI for anticancer therapy assessment. , 2002, European journal of cancer.
[11] C. Meyer,et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. , 2002, Molecular imaging.
[12] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[13] Jan Wolber,et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.
[14] A. Padhani,et al. Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.
[15] Risto A Kauppinen,et al. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.
[16] Jean-Philippe Galons,et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. , 2002, Neoplasia.
[17] J. M. Taylor,et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.
[18] Olav Haraldseth,et al. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.
[19] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[20] R. Gillies,et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.
[21] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.